Department of Health and Social Care (DHSC) has issued a medicine supply notification for Semaglutide (Ozempic®) 1mg/0.74ml solution for injection 3ml pre-filled disposable device.


Tier 2 – medium impact

Date of issue 30th September 2022

Ozempic® 1mg solution for injection is out of stock until week commencing 17th October 2022. Thereafter, supply will only be available for existing patients until January 2023.
Ozempic® 0.5mg solution for injection remains available but can only support a partial uplift in demand.
Dulaglutide is unable to support any uplift in demand (see MSN/2022/079)
Alternative oral and parenteral GLP-1 receptor agonists (RAs) remain available (see supporting information for further details).

A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

The post Medicine Supply Notification: Semaglutide (Ozempic® ) 1mg/0.74ml solution for injection 3ml pre-filled disposable device appeared first on PSNC Website.